(Q43647934)

25 November 2017

title

The prolactin response to sulpiride in major depression: the role of the D2 receptor in depression (English)

1 reference

25 November 2017

2

1 reference

25 November 2017

Verbeeck WJ

1

1 reference

25 November 2017

Paiker J

series ordinal

3

1 reference

25 November 2017

Jersky B

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

European Neuropsychopharmacology

25 November 2017

published in

1 reference

25 November 2017

volume

11

1 reference

25 November 2017

issue

3

1 reference

25 November 2017

page(s)

215-220

1 reference

Prolactin response to the dopamine antagonist, metoclopramide, in depression

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Dopaminergic and opioidergic mediations of tricyclic antidepressants in the learned helplessness paradigm.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Involvement of serotonin and dopamine in the mechanism of action of novel antidepressant drugs: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Reduced dopamine turnover in the basal ganglia of depressed suicides.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Amisulpride versus amineptine and placebo for the treatment of dysthymia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Chronic antidepressant drug treatment reduces turning behavior and increases dopamine levels in the medial prefrontal cortex.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Electroconvulsive therapy and the brain: evidence for increased dopamine-mediated responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Effects of selective activation of dopamine D2 and D3 receptors on prolactin secretion and the activity of tuberoinfundibular dopamine neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Prolactin response to sulpiride before and after sleep deprivation in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Reduced cerebrospinal HVA concentrations and HVA/5-HIAA ratios in suicide attempters. Monoamine metabolites in 120 suicide attempters and 47 controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Dopaminergic agonist nomifensine compared with amitriptyline: a double- blind clinical trial in acute primary depressions

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Dopaminergic sensitivity and prediction of antidepressant response.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Drug-induced changes in prolactin secretion. Clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

The prolactin response to metoclopramide is increased in depression and in euthymic rapid cycling bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Blunted prolactin response. A neuroendocrine abnormality manifested by depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Role of the dopaminergic system in depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Repeated administration of antidepressants enhances agonist affinity for mesolimbic D2-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Dopamine D2 receptor binding before and after treatment of major depression measured by [123I]IBZM SPECT.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Striatal dopamine transporter density in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

In vivo evidence for the involvement of dopamine-D2 receptors in striatum and anterior cingulate gyrus in major depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Amisulpride versus imipramine and placebo in dysthymia and major depression. Amisulpride Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Effects of Fluvoxamine Treatment on the in Vivo Binding of [F-18]FESP in Drug Naive Depressed Patients: A Pet Study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Parallel changes in dopamine D2 receptor binding in limbic forebrain associated with chronic mild stress-induced anhedonia and its reversal by imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Dopaminergic hypothesis for retarded depression: a symptom profile for predicting therapeutical responses

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Antidepressant action of sulpiride. Results of a placebo-controlled double-blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Clinical and psychometric correlates of dopamine D2 binding in depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

In vivo microdialysis assessment of extracellular serotonin and dopamine levels in awake monkeys during sustained fluoxetine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

A randomized double blind group comparative study of sulpiride and amitriptyline in affective disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

A controlled comparison of flupenthixol decanoate injections and oral amitriptyline in depressed out-patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Serotonergic modulation of striatal D2 dopamine receptor binding in humans measured with positron emission tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

Chronic administration of l-sulpiride at non-neuroleptic doses reduces the duration of immobility in experimental models of "depression-like" behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0924-977X%2801%2900086-4

7 January 2021

10.1016/S0924-977X(01)00086-4

Identifiers

DOI

1 reference

25 November 2017

1 reference